Cytokines and anticytokines in the pathogenesis of sepsis

Infectious Disease Clinics of North America

Volumn 13, Issue 2, 1999, Pages 413-426

  Van der Poll, T ^a   Van Deventer, S J H ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

BACTERIAL INFECTION; CLINICAL TRIAL; HUMAN; IMMUNE RESPONSE; INFLAMMATION; PATHOGENESIS; REVIEW; SEPSIS; TREATMENT FAILURE;

EID: 0032997973     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5520(05)70083-0     Document Type: Article

References (56)

1. R.D. Acton P.S. Dahlberg M.E. Uknis Differential sensitivity to Escherichia coli infection in mice lacking tumor necrosis factor p55 or interleukin-1 p80 receptors Arch Surg 131 1996 1216
2. D. Aderka J. Le J. Vilcek IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells and in mice J Immunol 143 1989 3517
3. D. Aderka H. Engelmann Y. Maor Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors J Exp Med 175 1992 323
4. F. Bazzoni B. Beutler The tumor necrosis factor ligand and receptor families N Engl J Med 334 1996 1717
5. D.J. Berg R. Kühn K. Rajewsky Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance J Clin Invest 96 1995 2339
6. B. Beutler I.W. Milsark A. Cerami Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin Science 229 1985 869
7. U. Boehm T. Klamp M. Groot Cellular responses to interferon-γ Annu Rev Immunol 15 1997 749
8. R.C. Bone C.J. Grodzin R.A. Balk Sepsis: A new hypothesis for pathogenesis of the disease process Chest 112 1997 235
9. B.D. Car V.M. Eng B. Schnyder Interferon γ receptor deficient mice are resistant to endotoxic shock J Exp Med 179 1994 1437
10. S.A. Dalrymple R. Slattery D.M. Aud Interleukin-6 is required for a protective immune response to systemic Escherichia coli infection Infect Immun 64 1996 3231
11. M.S. Dehoux A. Boutten J. Ostinelli Compartmentalized cytokine production within the human lung in unilateral pneumonia Am J Respir Crit Care Med 150 1994 710
12. C.A. Dinarello Biologic basis for interleukin-1 in disease Blood 87 1996 2095
13. W.D. Döcke F. Randow U. Syrbe Monocyte deactivation in septic patients: Restoration by IFN-γ treatment Nat Med 3 1997 678
14. B. Echtenacher W. Falk D.N. Mannel Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis J Immunol 145 1990 3762
15. G. Fantuzzi H. Zheng R. Faggioni Effect of endotoxin in IL-1β-deficient mice J Immunol 157 1996 291
16. E. Fischer M.A. Marano van Zee K.J. Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia J Clin Invest 89 1992 1551
17. C.J. Fisher J. Agosti S.M. Opal Treatment of septic shock with the tumor necrosis factor receptor: Fc fusion protein N Engl J Med 334 1996 1697
18. D. Fröhlich R.M. Eiber M. Jochum Perioperative pattern of peritoneal interleukin 8, tumour necrosis factor-α, and granulocyte elastase release in human secondary peritonitis Cytokine 9 1997 288
19. C. Gérard C. Bruyns A. Marchant Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia J Exp Med 177 1993 547
20. M.B. Glaccum K.L. Stocking K. Charrier Phenotypic and functional characterization of mice that lack the type I receptor for IL-1 J Immunol 159 1997 3364
21. M.J. Greenberger S.L. Kunkel R.M. Strieter IL-12 gene therapy protects mice in lethal Klebsiella pneumonia J Immunol 157 1996 3006
22. D.G. Hesse K.J. Tracey Y. Fong Cytokine appearance in human endotoxemia and primate bacteremia Surgery Gynecology and Obstetrics 166 1988 147
23. T. Kishimoto S. Akira M. Narazaki Interleukin-6 family of cytokines and gp130 Blood 86 1995 1243
24. M. Kopf H. Baumann G. Freer Impaired immune and acute-phase responses in interleukin-6-deficient mice Nature 368 1994 339
25. S.F. Lowry S.E. Calvano van der Poll T. Measurement of Inflammatory Mediators in clinical sepsis Sibbald W.J. Vincent J.L. Clinical Trials for the Treatment of Sepsis 1995 Springer-Verlag New York 86
26. A. Marchant C. Bruyns P. Vandenabeele IL-10 controls IFN-γ and TNF production during experimental endotoxemia Eur J Immunol 24 1994 1167
27. A. Marchant J. Deviere B. Byl Interleukin-10 production during septicaemia Lancet 343 1994 707
28. K.W. Moore A. O'Garra de Waal Malefyt R. Interleukin-10 Annu Rev Immunol 11 1993 165
29. C. Munoz J. Carlet C. Fitting Dysregulation of in vitro cytokine production by monocytes during sepsis J Clin Invest 88 1991 1747
30. A.C. Ogilvie C.E. Hack J. Wagstaff IL-1β does not cause neutrophil degranulation but does lead to IL-6, IL-8, and nitrite/nitrate release when used in patients with cancer J Immunol 156 1996 389
31. K. Ohlsson P. Björk M. Bergenfeldt Interleukin 1 receptor antagonist reduces mortality from endotoxin shock Nature 348 1990 550
32. S. Okusawa J.A. Gelfland T. Ikejima Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition J Clin Invest 81 1988 1162
33. D. Pajkrt L. Camoglio Tiel-van Buul M.C.M. Attenuation of proinflammatory response by recombinant human IL-10 in human endotoxemia; the effect of timing of rhIL-10 administration J Immunol 158 1997 3971
34. Pajkrt D. van der Poll T. M. Levi Interleukin 10 inhibits activation of coagulation and fibrinolysis during human endotoxemia Blood 89 1997 2701
35. K. Pfeffer T. Matsuyama T.M. Kündig Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection Cell 73 1993 457
36. L. Romani P. Pucetti F. Bistoni Interleukin-12 in infectious diseases Clin Microbiol Rev 10 1997 611
37. J. Rothe W. Lesslauer H. Lötscher Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes Nature 364 1993 798
38. A.T. Silva J. Cohen Role of interferon-γ in experimental gram-negative sepsis J Infect Dis 166 1992 331
39. J.M.L. Stouthard M. Levi C.E. Hack Interleukin 6 stimulates coagulation, not fibrinolysis, in humans Thromb Haemost 76 1996 738
40. H. Tilg E. Trehu M.B. Atkins Interleukin-6 (IL-6) as an antiinflammatory cytokine: Induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55 Blood 83 1994 113
41. K.J. Tracey B. Beutler S.F. Lowry Shock and tissue injury induced by recombinant human cachectin Science 234 1986 470
42. G. Trinchieri Interleukin-12 and interferon-γ Do they always go together? Am J Pathol 147 1995 1534
43. Van der Poll T. H.R. Büller ten Cate H. Activation of coagulation after administration of tumor necrosis factor to normal subjects N Engl J Med 322 1990 1622
44. Van der Poll T. van Deventer S.J.H. C.E. Hack Effects on leukocytes following injection of tumor necrosis factor into healthy humans Blood 79 1992 693
45. Van der Poll T. M. Levi C.E. Hack Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees J Exp Med 179 1994 1253
46. Van der Poll T. S.F. Lowry Tumor necrosis factor in sepsis: Mediator of multiple organ failure or essential part of host defense? Shock 3 1995 1
47. Van der Poll T. S.F. Lowry Endogenous Mechanisms Regulating TNF and IL-1 during Sepsis Vincent J.L. Yearbook of Intensive Care and Emergency Medicine 1995 Springer-Verlag New York 385
48. Van der Poll T. S.M. Coyle L.L. Moldawer Changes in endotoxin-induced cytokine production by whole blood after in vivo exposure of normal humans to endotoxin J Infect Dis 174 1996 1356
49. Van der Poll T. A. Marchant C.V. Keogh Interleukin-10 impairs host defense in murine pneumococcal pneumonia J Infect Dis 174 1996 994
50. Van der Poll T. C.V. Keogh W.A. Buurman Passive immunization against tumor necrosis factor alpha impairs host defense during pneumococcal pneumonia Am J Respir Crit Care Med 155 1997 603
51. Van der Poll T. C.V. Keogh X. Guirao Interleukin-6 gene deficient mice show impaired defense against streptococcal pneumonia J Infect Dis 176 1997 439
52. Van Deuren M. Van der Ven-Jongekrijg J. P.N.M. Demacker Differential expression of proinflammatory cytokines and their inhibitors during the course of meningococcal infections J Infect Dis 169 1994 157
53. Van Zee K.J. T. Kohno E. Fischer Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor α in vitro and in vivo Proc Natl Acad Sci U S A 89 1992 4845
54. Van Zee K.J. S.A. Stackpole W.J. Montegut A human tumor necrosis factor (TNF) α mutant that binds exclusively to the p55 TNF receptor produces toxicity in the baboon J Exp Med 179 1994 1185
55. M. Wysocka M. Kubin L.Q. Vieira Interleukin-12 is required for interferon-γ production and lethality in lipopolysaccharide-induced shock in mice Eur J Immunol 25 1995 672
56. F. Zeni B. Freeman C. Natanson Anti-inflammatory therapies to treat sepsis and septic shock: A reassessment Crit Care Med 25 1997 1095